WHAT THE STUDY ACTUALLY SAYS

Lebanon investigated only 52% of suspected measles cases adequately, a review finds

An analysis of a decade of surveillance data shows the system leans heavily on hospitals and misses cases in the community — the weakness that lets measles circulate undetected between outbreaks.

Suspected measles/rubella cases in Lebanon's outbreak years2013: 1760; 2018–2019: 1984; 2023–2024: 346010002000201317602018–201919842023–2024346
Suspected measles/rubella cases in Lebanon's outbreak years
GroupValue (value)
20131760
2018–20191984
2023–2024346
Suspected measles/rubella cases in Lebanon's outbreak years Counts of suspected cases notified during the three outbreak periods identified in the review. Source: Epidemiologia (MDPI)

Measles elimination is not achieved by vaccination alone. It also requires surveillance sensitive enough to detect the virus when it slips through — because a case that is never investigated is a chain of transmission that is never broken. A review published in Epidemiologia on 14 May assesses how well Lebanon's surveillance system performs against that standard [s1].

What was assessed

Lebanon adopted the World Health Organization's regional strategic plan for measles elimination, which ran from 2012 to 2020, and the review analysed suspected measles and rubella cases notified to the national epidemiological surveillance programme between January 2013 and December 2024 [s1]. A suspected case was defined as any patient with a febrile maculopapular rash, or one clinically judged compatible by a physician [s1]. That broad definition is deliberate: elimination surveillance is meant to cast a wide net and then rule cases out with laboratory testing, so a system working well should report many suspected cases and discard most of them as something other than measles or rubella.

The authors measured the WHO performance indicators: how completely cases were investigated, how quickly investigations began, what share were laboratory-tested, and the notification rate of discarded non-measles cases [s1]. Mean proportions and standard deviations were calculated across years and across provinces, which is what lets the review show not just the national average but how much performance varied [s1].

The numbers

A total of 6,581 suspected cases were reported over the period, 66% of them from hospitals [s1]. Outbreaks occurred in 2013 (1,760 cases), 2018–2019 (1,984 cases) and 2023–2024 (346 cases) [s1]. Outside outbreak years, the notification rate ranged between 0.7 and 1.8 per 100,000 population [s1].

The performance indicators tell the core story. Timely investigation — completed within 48 hours — was achieved in 72% of cases, but with wide variability (±30%) [s1]. Adequate investigation, meaning the demographic and vaccination data were complete, reached only 52% (±19%) [s1]. Laboratory testing was performed in 62% of cases (±16%) [s1].

Each of those gaps has a concrete consequence. A case not investigated within 48 hours is one where contacts may already have been exposed before anyone traces them. A case investigated without complete vaccination data cannot tell public-health officials whether the child was unvaccinated, under-vaccinated or a vaccine failure — the information that says whether an outbreak reflects a coverage gap or something else. And a case never laboratory-tested cannot be confirmed or discarded, leaving the count uncertain in both directions [s1].

Why hospital-heavy reporting is a weakness

The finding that two-thirds of cases came from hospitals is not reassuring; it is the problem. A surveillance system that mostly hears about measles when a patient is sick enough to be admitted is one that is missing milder cases in the community — exactly the cases that keep the virus circulating undetected. High-performing elimination surveillance is expected to pick up suspected cases from outpatient and primary-care settings, discard the non-measles ones through testing, and confirm the rest quickly. The wide standard deviations the review reports also point to unevenness across provinces and years, meaning the national averages conceal places and periods where performance was worse [s1].

What it does and doesn't say

This is a review of routine surveillance data, and its indicators describe how the system operated, not how many true measles infections occurred — an under-sensitive system will always undercount. The authors do not claim Lebanon has failed to eliminate measles; they document specific weaknesses in the apparatus that would be needed to verify elimination [s1]. The 2023–2024 outbreak of 346 cases is smaller than the two earlier ones, but a review of surveillance performance cannot say whether that reflects genuinely less transmission or less detection [s1].

The conclusion is a systems point: Lebanon's surveillance showed suboptimal sensitivity, an over-reliance on hospital reporting, and variable completeness, and the authors call for strengthening outpatient reporting and continuous training of health professionals [s1]. Those are the levers that would let the country demonstrate whether it is actually holding measles down.

The stakes are not hypothetical. A separate systematic review of infectious disease in Lebanon during the Syrian refugee crisis lists measles among the diseases reported to have increased in burden, alongside other vaccine-preventable and water-borne infections [s2]. Measles is among the most transmissible human viruses, and it exploits exactly the combination this surveillance review describes — pockets of under-vaccination and a detection system that hears about cases late. Whether elimination is within reach depends less on any single outbreak count than on whether the apparatus can find and confirm cases fast enough to break transmission before it spreads.

Sources

  1. How Is Lebanon's Progress Towards Measles Elimination? Review of Surveillance Performance Indicators, 2013–2024Epidemiologia (MDPI) , May 14, 2026
  2. Impact of the late Syrian crisis on infectious diseases in Lebanon: a systematic reviewPublic Health (Elsevier) , April 30, 2026

More on

Related coverage